Latest News

September 2019

in newsSepsis

Thermo Fisher Scientific Supports Sepsis Awareness Month in September

Thermo Fisher Scientific Inc., the world leader in serving science, announces its support of Sepsis Awareness Month to drive awareness around sepsis, a complex clinical syndrome and a leading cause of death globally.

Thermo Fisher Scientific Supports Sepsis Awareness Month in September >

 


August 2019

in newsAntimicrobial Stewardship

PCT leads the way in antimicrobial stewardship

Antibiotic treatment of sepsis patients often has to rely on clinical observation and educated guesswork as clinicians wait for a culture to determine whether the infection is bacterial, viral, or possibly fungal.

Read the news article here >


July 2019

newsPatent

Validity of B·R·A·H·M·S’ patent confirmed by German Federal Patent Court

Again, B·R·A·H·M·S GmbH (B·R·A·H·M·S) has successfully defended one of its many patents relating to Procalcitonin (PCT) in diagnostics and therapy around sepsis and infectious diseases.

Read the news on thermoscientific.com/brahms >


July 2019

publicationIn Vitro Diagnostics

PCT included in Second WHO Model List of Essential In Vitro Diagnostics

Procalcitonin – to guide antibiotic therapy/discontinuation in sepsis and lower respiratory tract infection

Second WHO Model List of Essential In Vitro Diagnostics >


July 2019

in newsAntibiotic Resistance

Rapid Diagnostic Testing Helps Rule Out Bacterial Infections, Decreasing Antibiotic Use

A pharmacist-led protocol using rapid diagnostic testing to rule out methicillin-resistant Staphylococcus aureus (MRSA) pulmonary infections at an Ohio hospital last year led to 80% of patients being de-escalated on vancomycin within 24 hours of receiving negative test results.

Read the news article here >


May 2019

press-releaseHealth Economics

U.S. Health Economic Analysis Demonstrates the Cost Reduction Impact of using B·R·A·H·M·S PCT to Support Antibiotic Stewardship Versus Standard of Care

Outcome shows a reduction in antibiotic days, shorter length of stay, shorter duration of mechanical ventilation, and fewer patients at risk for antibiotic resistance or C.difficile infection lead to incremental reduction of costs of 26 percent in sepsis and 17.7 percent in lower respiratory tract infection

Read the press release here >


February 2019

current-eventSepsis

2019 Sepsis Survivor Week, February 10th-16th

Up to 60% of sepsis survivors are left not only with physical challenges but mental and emotional challenges too.

Download Life After Sepsis video and infographics >

Learn more and find resources for sepsis survivors >


News Archive

thermo scientific applied biosystems invitrogen fisher scientific unity lab service